Executives
-
Galvin RoyPresident, Global Plasma & BC -
Miller Laurie A.SVP, Human Resources
-
Simon, ChristopherPresident & CEO
-
Strong Stewart WPresident, Global Hospital
-
Lingamneni AnilaEVP, Chief Technology Officer
-
Llorens JosepEVP, Global Manufacturing
-
Basil Michelle LEVP and General Counsel
-
Maunsell Farris MaryanneVP, Chief Accounting Officer
-
Darecca JamesEVP, Chief Financial Officer
?
Darecca James
EVP, Chief Financial Officer
Haemonetics Corporation
US, Boston [HQ]
CIK
1583903
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
13,258
Price per Share :
$73.49
Equivalence :
$974,330.42
Transaction History
-
F13,258 Shares After TransactionValue : $1,279,264.42$39,753.88Transaction Date : 05/15/24
-
Footnotes
-
-
Footnotes:#1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.#2 This number includes unvested RSUs previously reported.
-
F12,907 Shares After TransactionValue : $1,223,583.60$33,274.80Transaction Date : 05/16/24
-
Footnotes
-
-
Footnotes:#1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.#2 This number includes unvested RSUs previously reported.
-
A17,346 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/17/24
-
Footnotes
-
-
Footnotes:#1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.#2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.#3 This number includes unvested RSUs previously reported.
-
F13,670 Shares After TransactionValue : $1,275,821.10$40,318.56Transaction Date : 05/02/24
-
Footnotes
-
-
Footnotes:#1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.#2 This number includes unvested RSUs previously reported.